Large scale adeno-associated virus production systems
AssigneeBiomarin Pharmaceutical Inc.
InventorsTomas CINEK, Joseph Charles PELTIER, Juan Jose APONTE-UBILLUS, Daniel BARAJAS, Santosh G. PANDE
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiomarin Pharmaceutical Inc.
InventorsTomas CINEK, Joseph Charles PELTIER, Juan Jose APONTE-UBILLUS, Daniel BARAJAS, Santosh G. PANDE
Estimating the term…
The present invention provides processes for producing and characterizing adenoassociated virus particles and baculovirus particles. The present invention is directed to methods of improving adeno associated virus (AAV) production. The present invention addresses the problems associated with the production of rAAV using baculovirus infected Sf9 cells and achieves an improved method for producing rAAV. The present invention developed different methods for producing recombinant baculovirus (rBV) and recombinant adeno-associated virus (rAA V). These methods address issues such as genome instability and also result in improved production of rAA V, as well as produce rAA V with improved properties.
A method of producing recombinant adeno-associated virus (rAAV), the method comprising the steps of:
-3. (canceled)
A method of producing recombinant adeno-associated virus (rAAV), the method comprising the steps of:
-26. (canceled)
-41. (canceled)
A composition comprising recombinant adeno-associated virus (rAAV), wherein the rAAV has at least one of:
Dependencies are inferred from the claim text.